Jpmorgan Chase & CO Cue Health Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Cue Health Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 263 shares of HLTH stock, worth $2. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263
Previous 258
1.94%
Holding current value
$2
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HLTH
# of Institutions
62Shares Held
66.6MCall Options Held
0Put Options Held
0-
Tarsadia Capital, LLC New York, NY10.7MShares$106,8476.24% of portfolio
-
Oakmont Corp9.6MShares$95,9530.45% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC8.98MShares$89,8092.19% of portfolio
-
Decheng Capital LLC Menlo Park, CA8.98MShares$89,8090.23% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA7.08MShares$70,7850.18% of portfolio
About Cue Health Inc.
- Ticker HLTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 148,152,992
- Market Cap $1.48M
- Description
- Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of ...